Top

Published in:

01-03-2013 | Original paper

Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case–control study (the Bellvitge Colorectal Cancer Study)

Authors: Raul Zamora-Ros, Carla Not, Elisabeth Guinó, Leila Luján-Barroso, Raul M. García, Sebastiano Biondo, Ramón Salazar, Victor Moreno

Published in: Cancer Causes & Control | Issue 3/2013

Abstract

Background

Flavonoid-rich foods, such as fruits, vegetables, and tea, may have a protective effect upon colorectal cancer. However, current epidemiological evidence for a protective effect of flavonoid intake upon colorectal cancer is promising but not conclusive.

Objective

To examine the relation between dietary flavonoid and lignan intakes and the risk of colorectal cancer within a Spanish population.

Design

Data from the Bellvitge Colorectal Cancer Study, a case–control study (424 cases with incident colorectal cancer and 401 hospital-based controls), were used. A reproducible and validated food frequency questionnaire was administered in personal interviews. An ad hoc food composition database on flavonoids and lignans was compiled, mainly using data from the US Department of Agriculture and Phenol-Explorer databases. Adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated using unconditional logistic regression models.

Results

An inverse association was found between intake of total flavonoids (OR, 0.59; 95 % CI, 0.35–0.99 for the highest vs. the lowest quartile; p for trend = 0.04), lignans (OR, 0.59; 95 % CI, 0.34–0.99; p for trend = 0.03), and some individual flavonoid subgroups (flavones, proanthocyanidins) and the risk of colorectal cancer. Separate analyses by cancer site showed similar results.

Conclusions

Intake of total dietary flavonoids (particularly certain flavonoid subgroups) and lignans was inversely associated with colorectal cancer risk in a Spanish population.

World Research Cancer Fund, American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington

Perez-Jimenez J, Neveu V, Vos F, Scalbert A (2010) Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. Eur J Clin Nutr 64(Suppl 3):S112–S120PubMedCrossRef

de Kok TM, van Breda SG, Manson MM (2008) Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47(Suppl 2):51–59PubMedCrossRef

Kampa M, Nifli AP, Notas G, Castanas E (2007) Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol 159:79–113PubMedCrossRef

Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher AJ (2007) Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? Int J Cancer 120:451–458PubMedCrossRef

Curtis PJ, Sampson M, Potter J, Dhatariya K, Kroon PA, Cassidy A (2012) Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Diabetes Care 35:226–232PubMedCrossRef

Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S, Tunon MJ (2010) Fruit polyphenols, immunity and inflammation. Br J Nutr 104(Suppl 3):S15–S27PubMedCrossRef

Sun CL, Yuan JM, Koh WP, Yu MC (2006) Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27:1301–1309PubMedCrossRef

Akhter M, Iwasaki M, Yamaji T, Sasazuki S, Tsugane S (2009) Dietary isoflavone and the risk of colorectal adenoma: a case-control study in Japan. Br J Cancer 100:1812–1816PubMedCrossRef

10.

Theodoratou E, Kyle J, Cetnarskyj R et al (2007) Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16:684–693PubMedCrossRef

11.

Rossi M, Negri E, Talamini R et al (2006) Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15:1555–1558PubMedCrossRef

12.

Rossi M, Negri E, Parpinel M et al (2010) Proanthocyanidins and the risk of colorectal cancer in Italy. Cancer Causes Control 21:243–250PubMedCrossRef

13.

Kyle JAM, Sharp L, Little J, Duthie GG, McNeill G (2010) Dietary flavonoid intake and colorectal cancer: a case-control study. Br J Nutr 103:429–436PubMedCrossRef

14.

Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P (2006) Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136:3046–3053PubMed

15.

Bobe G, Sansbury LB, Albert PS et al (2008) Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17:1344–1353PubMedCrossRef

16.

Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, Sesso HD (2009) Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89:905–912PubMedCrossRef

17.

Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S (2008) Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study. Cancer Epidemiol Biomarkers Prev 17:2128–2135PubMedCrossRef

18.

Mursu J, Nurmi T, Tuomainen TP, Salonen JT, Pukkala E, Voutilainen S (2008) Intake of flavonoids and risk of cancer in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer 123:660–663PubMedCrossRef

19.

Lin J, Zhang SM, Wu K, Willett WC, Fuchs CS, Giovannucci E (2006) Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 164:644–651PubMedCrossRef

20.

Knekt P, Kumpulainen J, Jarvinen R et al (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560–568PubMed

21.

Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P (2001) Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12:789–796PubMedCrossRef

22.

Knekt P, Jarvinen R, Seppanen R et al (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146:223–230PubMedCrossRef

23.

Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s Health Study (United States). Cancer Causes Control 13:373–382PubMedCrossRef

24.

Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, Khaw KT (2010) Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 91:440–448PubMedCrossRef

25.

Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S (2008) Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 17:2891–2894PubMedCrossRef

26.

Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(Suppl 1):230S–242SPubMed

27.

Landi S, Bottari F, Gemignani F et al (2007) Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur J Cancer 43:762–768PubMedCrossRef

28.

EPIC Group of Spain (1997) Relative validity and reproducibility of a diet history questionnaire in Spain. I. Foods. Int J Epidemiol 26(Suppl 1):S91–S99

29.

EPIC Group of Spain (1997) Relative validity and reproducibility of a diet history questionnaire in Spain. II. Nutrients. Int J Epidemiol 26(Suppl 1):S100–S109

30.

Slimani N, Deharveng G, Unwin I et al (2007) The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 61:1037–1056PubMedCrossRef

31.

Knaze V, Zamora-Ros R, Luján-Barroso L et al. (2011) Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. doi:10.1017/S0007114511006386

32.

Zamora-Ros R, Knaze V, Luján-Barroso L et al (2011) Estimation of the intake of anthocyanidins and their food sources in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 106:1090–1099PubMedCrossRef

33.

Zamora-Ros R, Knaze V, Luján-Barroso L, Slimani N, Romieu I, Fedirko V (2011) Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-h dietary recall cohort. Br J Nutr 106:1915–1925PubMedCrossRef

34.

Zamora-Ros R, Knaze V, Luján-Barroso L et al. (2012) Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr. doi:10.1038/ejcn.2012.36

35.

U.S. Department of Agriculture (2007) USDA database for the flavonoid content of selected foods. Release 2.1 ed. U.S. Department of Agriculture, Beltsville

36.

U.S. Department of Agriculture (2008) USDA database for the isoflavone content of selected foods. Release 2.0 ed. U.S. Department of Agriculture, Beltsville

37.

U.S. Department of Agriculture (2004) USDA database for the proanthocyanidin content of selected foods. U.S. Department of Agriculture, Beltsville

38.

Neveu V, Perez-Jimenez J, Vos F et al (2010) Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxf) 2010:bap024CrossRef

39.

Willett W, Sampfer MJ (1986) Total energy intake: implications for epidemiological analyses. Am J Epidemiol 124:17–27PubMed

40.

Pierini R, Gee JM, Belshaw NJ, Johnson IT (2008) Flavonoids and intestinal cancers. Br J Nutr 99(Suppl. 1):ES53–ES59PubMed

41.

Hoensch HP, Kirch W (2005) Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int J Gastrointest Cancer 35:187–195PubMedCrossRef

42.

Williamson G, Clifford MN (2010) Colonic metabolites of berry polyphenols: the missing link to biological activity? Br J Nutr 104(Suppl 3):S48–S66PubMedCrossRef

43.

Kramer F, Johnson IT, Doleman JF, Lund EK (2009) A comparison of the effects of soya isoflavonoids and fish oil on cell proliferation, apoptosis and the expression of oestrogen receptors alpha and beta in the mammary gland and colon of the rat. Br J Nutr 102:29–36PubMedCrossRef

44.

Bielecki A, Roberts J, Mehta R, Raju J (2011) Estrogen receptor-beta mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer 63:139–150PubMed

45.

Schleipen B, Hertrampf T, Fritzemeier K et al (2011) ER{beta}-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Carcinogenesis 32:1675–1683PubMedCrossRef

46.

Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I—the analysis of case-control studies. IARC Sci Publ 32:5–338PubMed

47.

EPIC Group of Spain (1997) Relative validity and reproducibility of a diet history questionnaire in Spain. III. Biochemical markers. Int J Epidemiol 26(Suppl 1):S110–S117

Title: Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case–control study (the Bellvitge Colorectal Cancer Study)
Authors: Raul Zamora-Ros
Carla Not
Elisabeth Guinó
Leila Luján-Barroso
Raul M. García
Sebastiano Biondo
Ramón Salazar
Victor Moreno
Publication date: 01-03-2013
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 3/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-9992-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Design

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2013

An hypothesis on the presumed association between thyroid goiter and gastric cancer

Case–control study of lifetime alcohol intake and prostate cancer risk

Behavior theory for dietary interventions for cancer prevention: a systematic review of utilization and effectiveness in creating behavior change

Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case–control study in Connecticut and Massachusetts

Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4

HBV infection increases the risk of pancreatic cancer: a meta-analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer